Phase 1 Trial Shows Manageable Safety for CD123 CAR T Cells in Leukemia
A phase 1 clinical trial demonstrated that CD123-directed CAR T-cell therapy is feasible and well-tolerated in patients with relapsed or ...
A phase 1 clinical trial demonstrated that CD123-directed CAR T-cell therapy is feasible and well-tolerated in patients with relapsed or ...
A multi-center case series of eight CEBPA-mutated MPAL patients found high relapse and mortality among non-transplanted individuals despite frequent bZIP ...
A comprehensive review outlines how tumor-derived extracellular vesicles bridge minimally invasive cancer diagnosis, disease monitoring, and experimental therapeutic delivery.
A twenty-year retrospective review of nineteen pediatric acute promyelocytic leukemia patients evaluated clinical outcomes, treatment toxicity, and pediatric intensive care ...
A pilot study at Ain Shams University Hospitals evaluated flow cytometric RECAF expression across eighty pediatric acute leukemia patients and ...
A comprehensive review examines clinical and pharmacologic data demonstrating the efficacy and cardiac safety profile of zanubrutinib for chronic lymphocytic ...
A comprehensive review evaluates how plasma cell-free DNA analyses support early breast cancer detection, molecular residual disease tracking, and treatment ...
In a study of 143 high-risk neuroblastoma patients, bone marrow CD14+CD206+ M2-like monocyte-macrophages demonstrated discriminatory ability for minimal residual disease ...
A phase 1/2 clinical trial demonstrated that dual-targeting BCMA and CD19 CAR T cells achieved deep hematologic and metabolic responses ...
A comprehensive scientific review outlines how circulating cell-free DNA, microRNA panels, and metabolic profiles could enhance early hepatocellular carcinoma surveillance ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine